Viewing Study NCT00651261


Ignite Creation Date: 2025-12-24 @ 12:59 PM
Ignite Modification Date: 2026-01-22 @ 12:46 PM
Study NCT ID: NCT00651261
Status: UNKNOWN
Last Update Posted: 2021-08-18
First Post: 2008-04-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult acute basophilic leukemia View
None adult acute eosinophilic leukemia View
None adult acute lymphoblastic leukemia View
None adult acute megakaryoblastic leukemia (M7) View
None adult acute minimally differentiated myeloid leukemia (M0) View
None adult acute monoblastic leukemia (M5a) View
None adult acute monocytic leukemia (M5b) View
None adult acute myeloblastic leukemia with maturation (M2) View
None adult acute myeloblastic leukemia without maturation (M1) View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None adult acute myelomonocytic leukemia (M4) View
None adult erythroleukemia (M6a) View
None adult pure erythroid leukemia (M6b) View
None untreated adult acute myeloid leukemia View